John Mann, co-director of the Center for the Prevention and Treatment of Depression at Columbia University, said in an interview the study marked a significant advance over earlier work that suggested GLP-1s can improve depression: "Whats been missing is randomized clinical control studies
Nearly all of the extra pounds lost in the triplet arm came from fat
[1] The medication is specifically formulated and FDA-approved for subcutaneous injection only meaning it should be administered into the fatty tissue layer beneath the skin, not into muscle tissue or blood vessels
Benzyl alcohol, while a robust preservative, is not invincible
For example, in response to the surging demand for tirzepatide (the active ingredient in its GLP-1 injections), Lilly built a manufacturing facility in Ireland capable of producing five metric tons of the drug per year
Metabolomics has also supported the identification of FFAR2, a short-chain fatty acid receptor, through correlation with plasma SCFA levels and metabolic phenotypes (151, 152)